Teva says to appeal against court decision in patent litigation
 Wednesday, March 21, 2007

 Teva says to appeal against court decision in patent litigation

Last Updated: 2007-03-21 15:00:30 -0400 (Reuters Health)

BANGALORE (Reuters) - Generic drugmaker Teva Pharmaceutical Industries Ltd. said it would appeal against a federal court's decision to uphold Pfizer Inc.'s patents on its arthritis drug Celebrex.

That decision bars Teva from launching a competing drug in the U.S. until December 2015.



Go Back 		 
Schwartzapfel Partners
With over 150 years of combined experience and highly competent co-counsel throughout the country, we can serve all your legal needs. Schwartzapfel Partners protects the rights of those who aren't able to do so themselves.    Learn More



Gender: Male Female
In what state did the incident occur?
Schwartzapfel Truhowsky Marcus
       Sachs P.C. disclaimer.

Clear